Terumo BCT
Terumo BCT, a global leader in blood component, therapeutic
apheresis and cellular therapy technologies, believes in the
potential of blood and cells to do even more for patients than
they do today. Terumo BCT’s Cell Therapy Technologies business
enables researchers, developers and manufacturers to create
next-generation cell and gene therapies. We do this through
flexible, automated solutions that help meet your evolving
needs for reproducibility, quality and scale through the phases
of development, from translational research to current good
manufacturing practice (cGMP) for commercial manufacturing.
One example, the Quantum® Cell Expansion System, automates
and optimizes cell culture to meet the needs of a variety of
cell types in a consistent, controlled and functionally closed
environment. We are also looking further downstream in the
process to provide innovative solutions, like the Finia® Fill and
Finish System, to support your needs into the future.